Complication Rates and Center Enrollment Volume in the Carotid Revascularization Endarterectomy Versus Stenting Trial

Authors:
  • NGNicole R. Gonzales
    Nicole R. Gonzales
  • BDBart M. Demaerschalk
    Bart M. Demaerschalk
  • JVJenifer H. Voeks
    Jenifer H. Voeks
  • MTMeeLee Tom
    MeeLee Tom
  • ASAlice J. Sheffet
    Alice J. Sheffet
  • LGLawrence Garcia
    Lawrence Garcia
  • DCDaniel G. Clair
    Daniel G. Clair
  • JBJohn Barr
    John Barr
  • SOSteven Orlow
    Steven Orlow

Abstract
Background and Purpose—: Evidence indicates that center volume of cases affects outcomes for both carotid endarterectomy and stenting. We evaluated the effect of enrollment volume by site on complication rates in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Methods—: The primary composite end point was any stroke, myocardial infarction, or death within 30 days or ipsilateral stroke in follow-up. The 477 approved surgeons performed >12 procedures per year with complication rates P =0.54) or by stroke and death ( P =0.87). A trend toward an inverse relationship between center enrollment volume and complications was mitigated by adjustment for known risk factors. Conclusions—: Complication rates were low in CREST and were not associated with center enrollment volume. The data are consistent with the value of rigorous training and credentialing in trials evaluating endovascular devices and surgical procedures. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00004732.

This publication has 23 references indexed in Scilit: